BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2013106)

  • 21. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of Infected Gr-1
    Abdissa K; Nerlich A; Beineke A; Ruangkiattikul N; Pawar V; Heise U; Janze N; Falk C; Bruder D; Schleicher U; Bogdan C; Weiss S; Goethe R
    Front Immunol; 2018; 9():2317. PubMed ID: 30386330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages.
    Appelberg R; Orme IM
    Immunology; 1993 Nov; 80(3):352-9. PubMed ID: 8288311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.
    Denis M
    J Leukoc Biol; 1991 Apr; 49(4):380-7. PubMed ID: 1900522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104.
    Saunders BM; Dane A; Briscoe H; Britton WJ
    Immunol Cell Biol; 2002 Dec; 80(6):544-9. PubMed ID: 12406388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of IL-12 in immunotherapy and vaccine design in experimental Mycobacterium avium infections.
    Silva RA; Pais TF; Appelberg R
    J Immunol; 1998 Nov; 161(10):5578-85. PubMed ID: 9820535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased mitogen-activated protein kinase activity and TNF-alpha production associated with Mycobacterium smegmatis- but not Mycobacterium avium-infected macrophages requires prolonged stimulation of the calmodulin/calmodulin kinase and cyclic AMP/protein kinase A pathways.
    Yadav M; Roach SK; Schorey JS
    J Immunol; 2004 May; 172(9):5588-97. PubMed ID: 15100302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchyma.
    Martins DR; Pelizon AC; Zorzella-Pezavento SF; Seger J; Santos Junior RR; Fonseca DM; Justulin LA; Silva CL; Sartori A
    Scand J Immunol; 2011 Apr; 73(4):293-300. PubMed ID: 21214611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections.
    Appelberg R
    Immunobiology; 1994 Oct; 191(4-5):520-5. PubMed ID: 7713566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy.
    Kobayashi K; Yamazaki J; Kasama T; Katsura T; Kasahara K; Wolf SF; Shimamura T
    J Infect Dis; 1996 Sep; 174(3):564-73. PubMed ID: 8769615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis.
    Feng CG; Kullberg MC; Jankovic D; Cheever AW; Caspar P; Coffman RL; Sher A
    Infect Immun; 2002 Dec; 70(12):6672-9. PubMed ID: 12438341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral infection of ferrets with virulent Mycobacterium bovis or Mycobacterium avium: susceptibility, pathogenesis and immune response.
    Cross ML; Labes RE; Mackintosh CG
    J Comp Pathol; 2000 Jul; 123(1):15-21. PubMed ID: 10906251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
    Castro AG; Minóprio P; Appelberg R
    Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin L maturation and activity is impaired in macrophages harboring M. avium and M. tuberculosis.
    Nepal RM; Mampe S; Shaffer B; Erickson AH; Bryant P
    Int Immunol; 2006 Jun; 18(6):931-9. PubMed ID: 16636015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.
    Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S
    J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads.
    Ehlers S; Kutsch S; Benini J; Cooper A; Hahn C; Gerdes J; Orme I; Martin C; Rietschel ET
    Immunology; 1999 Nov; 98(3):313-23. PubMed ID: 10583588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium avium infection in mice is associated with time-related expression of Th1 and Th2 CD4+ T-lymphocyte response.
    Azouaou N; Petrofsky M; Young LS; Bermudez LE
    Immunology; 1997 Jul; 91(3):414-20. PubMed ID: 9301531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of plasmid interleukin-12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette-Guèrin) in protecting against systemic Mycobacterim avium infection.
    Martin E; Kamath AT; Briscoe H; Britton WJ
    Immunology; 2003 Jun; 109(2):308-14. PubMed ID: 12757627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
    J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humoral immune response in humans and animals infected and immunized with Mycobacteria of the MAIS complex].
    Kalinina OA; Chernousova LN; Kulikovskaia NV; Kapina MA; Puzanov VA; Litvinov VI
    Probl Tuberk; 1994; (2):47-9. PubMed ID: 8036222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.